These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31801024)

  • 1. On the Origin of Lung Cancers.
    Pennycuick A; Janes SM
    Am J Respir Crit Care Med; 2020 Mar; 201(6):646-647. PubMed ID: 31801024
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating tumour DNA genomics in EGFR-mutant lung adenocarcinoma.
    Rosell R; Karachaliou N
    Lancet Respir Med; 2018 Sep; 6(9):649-651. PubMed ID: 30017883
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and Pathologic Implications of Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma.
    Xu X; Mao Y; Ding Q; Chen Y
    J Thorac Oncol; 2020 Dec; 15(12):e187-e188. PubMed ID: 33246596
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to the Letter to the Editor: Clinical and Pathologic Implications of Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma.
    Caso R; Jones DR
    J Thorac Oncol; 2020 Dec; 15(12):e188-e189. PubMed ID: 33246597
    [No Abstract]   [Full Text] [Related]  

  • 5. Genome-wide identification of bone metastasis-related microRNAs in lung adenocarcinoma by high-throughput sequencing.
    Xie L; Yang Z; Li G; Shen L; Xiang X; Liu X; Xu D; Xu L; Chen Y; Tian Z; Chen X
    PLoS One; 2013; 8(4):e61212. PubMed ID: 23593434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive targetable genotypes of younger patients with lung adenocarcinoma: a cBioPortal for cancer genomics data base analysis.
    Hou H; Zhang C; Qi X; Zhou L; Liu D; Lv H; Li T; Sun D; Zhang X
    Cancer Biol Ther; 2020; 21(1):26-33. PubMed ID: 31594446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Common Cell of Origin for Inflammatory Myofibroblastic Tumor and Lung Adenocarcinoma with ALK rearrangement.
    Nesteryuk V; Hamdani O; Gong R; Almog N; Alexander BM; Soosman S; Yoneda K; Ali SM; Borowsky AD; Riess JW
    Clin Lung Cancer; 2022 Dec; 23(8):e550-e555. PubMed ID: 36253270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic profiling of multiple primary cancers including synchronous lung adenocarcinoma and bilateral malignant mesotheliomas: Identification of a novel BAP1 germline variant.
    Shinozaki-Ushiku A; Kohsaka S; Kage H; Oda K; Miyagawa K; Nakajima J; Aburatani H; Mano H; Ushiku T
    Pathol Int; 2020 Oct; 70(10):775-780. PubMed ID: 32583627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative ketorolac may interact with patient-specific tumour genomics to modify recurrence risk in lung adenocarcinoma: an exploratory analysis.
    Connolly JG; Scarpa JR; Gupta HV; Tan KS; Mastrogiacomo B; Dycoco J; Caso R; Jones GD; Sanchez-Vega F; Adusumilli PS; Rocco G; Isbell JM; Bott MJ; Irie T; McCormick PJ; Fischer GW; Jones DR; Mincer JS
    Br J Anaesth; 2021 Sep; 127(3):e82-e85. PubMed ID: 34272058
    [No Abstract]   [Full Text] [Related]  

  • 10. A genetic portrait of metastatic seeds in lung adenocarcinoma.
    Wu Q; Hu G
    Cancer Cell; 2023 May; 41(5):828-830. PubMed ID: 37160102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomics driven-oncology: challenges and perspectives.
    Normanno N; Cree IA
    BMC Cancer; 2015 Mar; 15():141. PubMed ID: 25884512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Pathway Emerges to Interpret Lung Cancer Genomic Alterations.
    Blakely CM
    Clin Cancer Res; 2019 Dec; 25(24):7269-7271. PubMed ID: 31611281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Genomic Landscape of Lung Adenocarcinoma from Household Use of Smoky Coal.
    Zhang T; Hoang PH; Wong JYY; Yang K; Chen K; Wong MP; Vermeulen RCH; ; Huang Y; Chanock SJ; Rothman N; Lan Q; Landi MT;
    Am J Respir Crit Care Med; 2023 Sep; 208(6):733-736. PubMed ID: 37406454
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatic Copy-Number Alterations Contribute to Brain Metastasis.
    Cancer Discov; 2020 May; 10(5):638. PubMed ID: 32245821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subpleural bronchopulmonary cancers developed on cicatrix; one aspect of peripheral pulmonary adenocarcinoma].
    GALY P; CHARCOSSET ; JACOUTON ; PUTHOD ; THEOCARIS
    J Fr Med Chir Thorac; 1958; 12(5):518-33. PubMed ID: 13598861
    [No Abstract]   [Full Text] [Related]  

  • 16. Across the Globe: Proteogenomic Landscapes of Lung Cancer.
    Yanovich-Arad G; Geiger T
    Cell; 2020 Jul; 182(1):9-11. PubMed ID: 32649881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma.
    Zengin T; Önal-Süzek T
    BMC Bioinformatics; 2020 Sep; 21(Suppl 14):368. PubMed ID: 32998690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of synchronous primary lung adenocarcinomas with genomic sequencing.
    Berry D; Mahadevan M; Wick MR
    Ann Diagn Pathol; 2018 Jun; 34():42-44. PubMed ID: 29661726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemical analysis of a newly developed, mouse monoclonal p40 (BC28) antibody in lung, bladder, skin, breast, prostate, and head and neck cancers.
    Tacha D; Bremer R; Haas T; Qi W
    Arch Pathol Lab Med; 2014 Oct; 138(10):1358-64. PubMed ID: 24528495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Typical presentation of pulmonary lepidic adenocarcinoma: a rare case report.
    Azzeddine R; Rhorfi IA; Zegmout A; Souhi H; Elouazzani H; Abid A; Chahdi H; Tbouda M
    Pan Afr Med J; 2020; 36():11. PubMed ID: 32550974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.